JP2021512086A5 - - Google Patents
Info
- Publication number
- JP2021512086A5 JP2021512086A5 JP2020541528A JP2020541528A JP2021512086A5 JP 2021512086 A5 JP2021512086 A5 JP 2021512086A5 JP 2020541528 A JP2020541528 A JP 2020541528A JP 2020541528 A JP2020541528 A JP 2020541528A JP 2021512086 A5 JP2021512086 A5 JP 2021512086A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- subject
- dapanstril
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862624637P | 2018-01-31 | 2018-01-31 | |
| US62/624,637 | 2018-01-31 | ||
| PCT/US2019/016012 WO2019152627A1 (en) | 2018-01-31 | 2019-01-31 | Method for preventing or treating alzheimer's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512086A JP2021512086A (ja) | 2021-05-13 |
| JP2021512086A5 true JP2021512086A5 (https=) | 2022-01-31 |
| JP7290872B2 JP7290872B2 (ja) | 2023-06-14 |
Family
ID=67478566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020541528A Active JP7290872B2 (ja) | 2018-01-31 | 2019-01-31 | アルツハイマー病の予防又は治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11517554B2 (https=) |
| EP (1) | EP3746057B1 (https=) |
| JP (1) | JP7290872B2 (https=) |
| CN (1) | CN111670032A (https=) |
| CA (1) | CA3087865A1 (https=) |
| MX (1) | MX2020007941A (https=) |
| WO (1) | WO2019152627A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7229565B2 (ja) * | 2018-03-21 | 2023-02-28 | オラテック セラピューティクス リミティド ライアビリティ カンパニー | メラノーマを治療するための方法 |
| EP4045009A4 (en) * | 2019-10-14 | 2023-11-01 | Olatec Therapeutics LLC | METHOD FOR TREATING BREAST CANCER |
| CN117897151A (zh) * | 2021-08-19 | 2024-04-16 | 欧拉泰克治疗公司 | 用于治疗帕金森氏病的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2651407B1 (en) * | 2010-12-15 | 2016-12-21 | Olatec Industries LLC | 3-methanesulfonylpropionitrile for treating inflammation and pain |
| EP3563849A3 (en) * | 2012-10-25 | 2020-02-12 | The General Hospital Corporation | Combination therapies for the treatment of alzheimer's disease and related disorders |
| WO2014194166A1 (en) * | 2013-05-31 | 2014-12-04 | Regeneron Pharmaceuticals, Inc. | Methods of using il-1 antagonists to treat alzheimer's disease |
| WO2015165961A1 (en) * | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
| WO2016138425A1 (en) * | 2015-02-26 | 2016-09-01 | University Of Kentucky Research Foundation | Compositions and methods for treating retinal degradation |
-
2019
- 2019-01-31 CA CA3087865A patent/CA3087865A1/en active Pending
- 2019-01-31 JP JP2020541528A patent/JP7290872B2/ja active Active
- 2019-01-31 MX MX2020007941A patent/MX2020007941A/es unknown
- 2019-01-31 WO PCT/US2019/016012 patent/WO2019152627A1/en not_active Ceased
- 2019-01-31 CN CN201980011347.7A patent/CN111670032A/zh active Pending
- 2019-01-31 EP EP19746676.6A patent/EP3746057B1/en active Active
-
2020
- 2020-07-29 US US16/942,312 patent/US11517554B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2372421T3 (es) | Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopáusicos. | |
| JP2020033360A5 (https=) | ||
| JP2015519329A5 (https=) | ||
| JP2026035701A5 (https=) | ||
| JP2023523569A5 (https=) | ||
| JP2021502392A5 (https=) | ||
| JP2021512086A5 (https=) | ||
| KR970061244A (ko) | 치매 치료용 약학 조성물 | |
| BR112020008128A2 (pt) | comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| ES3006014T3 (en) | Use of nalfurafine for the treatment of demyelinating diseases | |
| JP2023523706A5 (https=) | ||
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| JP2019507786A5 (https=) | ||
| IL272834B2 (en) | Amantadine compositions, preparations thereof, and methods of use | |
| JP2016528171A5 (https=) | ||
| ES2242605T3 (es) | Uso de desoxipeganina para el tratamiento de la demencia de alzheimer. | |
| JP2023531930A5 (https=) | ||
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| JP2022505184A5 (https=) | ||
| JP2024531799A5 (https=) | ||
| JP6420923B1 (ja) | 医薬 | |
| JP2023535034A5 (https=) | ||
| JP2014037445A (ja) | 抵抗性統合失調症およびその他のｃｎｓ疾患の治療 | |
| ES2969657T3 (es) | Tratamiento de trastorno de síndrome postraumático |